• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients.

作者信息

Kaplan Allen P, Ghebrehiwet Berhane

机构信息

Pulmonary and Critical Care Division, the Medical University of South Carolina, Charleston, SC.

Division of Rheumatology, Allergy, and Clinical Immunology, SUNY Stony Brook, Stony Brook, NY.

出版信息

J Allergy Clin Immunol. 2021 Feb;147(2):507-509. doi: 10.1016/j.jaci.2020.10.025. Epub 2020 Oct 28.

DOI:10.1016/j.jaci.2020.10.025
PMID:33129885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7598417/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2dd/7598417/5cc56520d836/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2dd/7598417/5cc56520d836/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2dd/7598417/5cc56520d836/gr1_lrg.jpg

相似文献

1
Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients.缓激肽形成途径及其与补体的相互关系作为COVID-19患者肺水肿的一个病因
J Allergy Clin Immunol. 2021 Feb;147(2):507-509. doi: 10.1016/j.jaci.2020.10.025. Epub 2020 Oct 28.
2
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.SARS-CoV-2 通过激活补体和激肽系统加剧 COVID-19 病理。
Front Immunol. 2021 Nov 5;12:767347. doi: 10.3389/fimmu.2021.767347. eCollection 2021.
3
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?了解 COVID-19 的病理生理学：接触系统是否可能是关键？
Front Immunol. 2020 Aug 11;11:2014. doi: 10.3389/fimmu.2020.02014. eCollection 2020.
4
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.SARS-CoV-2 抗体介导补体和细胞驱动的炎症反应。
Front Immunol. 2021 Nov 2;12:767981. doi: 10.3389/fimmu.2021.767981. eCollection 2021.
5
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
6
[Age-dependent possible role of contact-activated blood coagulation factor XII as a potential contributor to the “bradykinin storm” in COVID-19 patients].[接触激活的凝血因子XII在COVID-19患者中作为“缓激肽风暴”潜在促成因素的年龄依赖性可能作用]
Orv Hetil. 2020 Dec 13;161(50):2099-2103. doi: 10.1556/650.2020.32075.
7
SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection.与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）相关的补体基因变异可能会失调替代途径的激活，从而影响感染的严重程度。
Mol Immunol. 2021 Jul;135:421-425. doi: 10.1016/j.molimm.2021.03.021. Epub 2021 Mar 26.
8
Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.去-精氨酸9缓激肽和缓激肽可能会引发新冠肺炎患者的细胞因子风暴。
Iran J Immunol. 2021 Mar;18(1):93-94. doi: 10.22034/iji.2021.89684.1962.
9
Pulmonary edema in COVID-19: Explained by bradykinin?新型冠状病毒肺炎中的肺水肿：缓激肽所致？
J Allergy Clin Immunol. 2020 Dec;146(6):1454-1455. doi: 10.1016/j.jaci.2020.08.038. Epub 2020 Sep 29.
10
COVID-19: disCOVering the role of complement system.新型冠状病毒肺炎：发现补体系统的作用
Clin Exp Rheumatol. 2020 Jul-Aug;38(4):587-591. Epub 2020 Jul 28.

引用本文的文献

1
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.抑肽酶（I）：了解宿主蛋白酶在 COVID-19 中的作用及药理调节其功能的重要性。
Int J Mol Sci. 2024 Jul 10;25(14):7553. doi: 10.3390/ijms25147553.
2
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.抑肽酶（II）：用于治疗 COVID-19 和其他病毒病的吸入式给药。
Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209.
3
Common cold.普通感冒

本文引用的文献

1
SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.SARS-CoV-2 作为失衡肾素-血管紧张素系统的一个因素：在白细胞介素-6 产生加剧的情况下的一个可疑因素。
J Immunol. 2020 Sep 1;205(5):1198-1206. doi: 10.4049/jimmunol.2000642. Epub 2020 Jul 17.
2
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
3
Early Insights into Immune Responses during COVID-19.
Front Allergy. 2023 Jun 22;4:1224988. doi: 10.3389/falgy.2023.1224988. eCollection 2023.
4
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know.补体与 COVID-19：三年过去了，我们知道了什么，不知道什么，以及我们应该知道什么。
Immunobiology. 2023 May;228(3):152393. doi: 10.1016/j.imbio.2023.152393. Epub 2023 May 11.
5
Immune response induced by novel coronavirus infection.新型冠状病毒感染诱导的免疫应答。
Front Cell Infect Microbiol. 2022 Oct 25;12:988604. doi: 10.3389/fcimb.2022.988604. eCollection 2022.
6
Coronavirus disease-19 infection and angioedema in African Americans: A case series.非裔美国人中的冠状病毒病-19感染与血管性水肿：病例系列
Otolaryngol Case Rep. 2022 Sep;24:100457. doi: 10.1016/j.xocr.2022.100457. Epub 2022 Jun 27.
7
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.关于缓激肽在 COVID-19 和炎症性疾病中的最新认识的全面综述。
Mol Biol Rep. 2022 Oct;49(10):9915-9927. doi: 10.1007/s11033-022-07539-2. Epub 2022 May 21.
8
Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.成年健康个体鼻分泌物和血浆中激肽肽谱变化的质谱研究。
J Transl Med. 2022 Mar 29;20(1):146. doi: 10.1186/s12967-022-03332-8.
9
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B receptor antagonism.金尼受体拮抗作用早期抑制支气管上皮细胞中 SARS-CoV-2 的复制。
J Mol Med (Berl). 2022 Apr;100(4):613-627. doi: 10.1007/s00109-022-02182-7. Epub 2022 Mar 5.
10
Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19.血管紧张素肽失调：COVID-19 发病机制中的谜团。
Mediators Inflamm. 2022 Feb 8;2022:7423537. doi: 10.1155/2022/7423537. eCollection 2022.
对 COVID-19 期间免疫反应的早期洞察。
J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8.
4
COVID-19 as an Acute Inflammatory Disease.COVID-19 作为一种急性炎症性疾病。
J Immunol. 2020 Jul 1;205(1):12-19. doi: 10.4049/jimmunol.2000413. Epub 2020 May 18.
5
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
6
Hereditary Angioedema.遗传性血管性水肿
N Engl J Med. 2020 Mar 19;382(12):1136-1148. doi: 10.1056/NEJMra1808012.
7
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
8
Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells.可溶性 gC1qR 是一种旁分泌信号，可诱导内皮细胞上 B1R 的表达。
J Immunol. 2014 Jan 1;192(1):377-84. doi: 10.4049/jimmunol.1302031. Epub 2013 Dec 6.
9
Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation.使用缺失突变体进行的结构-功能研究确定了gC1qR/p33的结构域是血管通透性和炎症的潜在治疗靶点。
Front Immunol. 2011 Nov 1;2. doi: 10.3389/fimmu.2011.00058.
10
The plasma bradykinin-forming pathways and its interrelationships with complement.血浆缓激肽形成途径及其与补体的相互关系。
Mol Immunol. 2010 Aug;47(13):2161-9. doi: 10.1016/j.molimm.2010.05.010.